{
  "id": "IN12108",
  "type": "CRS Insight",
  "typeId": "IN",
  "number": "IN12108",
  "active": true,
  "source": "CRSReports.Congress.gov",
  "versions": [
    {
      "source": "CRSReports.Congress.gov",
      "sourceLink": "https://crsreports.congress.gov/product/details?prodcode=IN12108",
      "id": "IN12108_2_2023-02-13",
      "date": "2023-02-13",
      "retrieved": "2023-03-07T04:03:21.641689",
      "title": "FDA Regulation of Blood and Blood Products: Recent Draft Guidance on Donor Eligibility",
      "summary": null,
      "type": "CRS Insight",
      "typeId": "IN",
      "active": true,
      "formats": [
        {
          "format": "PDF",
          "url": "https://crsreports.congress.gov/product/pdf/IN/IN12108/2",
          "sha1": "fcf0d80229984a7a2665ce0a8fb75d1410e934f0",
          "filename": "files/2023-02-13_IN12108_fcf0d80229984a7a2665ce0a8fb75d1410e934f0.pdf"
        },
        {
          "format": "HTML",
          "filename": "files/2023-02-13_IN12108_fcf0d80229984a7a2665ce0a8fb75d1410e934f0.html",
          "source": "pymupdf"
        }
      ],
      "source_dir": "crsreports.congress.gov"
    }
  ],
  "topics": [
    "Health Policy"
  ]
}